Skip to main content

Do platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents?: platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents.

Publication ,  Journal Article
Gurbel, PA; Tantry, US
Published in: Circulation
March 13, 2012

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

March 13, 2012

Volume

125

Issue

10

Start / End Page

1276 / 1287

Location

United States

Related Subject Headings

  • Ticlopidine
  • Thrombosis
  • Risk Factors
  • Receptors, Purinergic P2Y12
  • Purinergic P2Y Receptor Antagonists
  • Platelet Function Tests
  • Platelet Aggregation Inhibitors
  • Pharmacogenetics
  • Humans
  • Genotype
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Gurbel, Paul A., and Udaya S. Tantry. “Do platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents?: platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents.Circulation 125, no. 10 (March 13, 2012): 1276–87. https://doi.org/10.1161/CIRCULATIONAHA.111.031195.
Gurbel, Paul A., and Udaya S. Tantry. “Do platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents?: platelet function testing and genotyping improve outcome in patients treated with antithrombotic agents.Circulation, vol. 125, no. 10, Mar. 2012, pp. 1276–87. Pubmed, doi:10.1161/CIRCULATIONAHA.111.031195.

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

March 13, 2012

Volume

125

Issue

10

Start / End Page

1276 / 1287

Location

United States

Related Subject Headings

  • Ticlopidine
  • Thrombosis
  • Risk Factors
  • Receptors, Purinergic P2Y12
  • Purinergic P2Y Receptor Antagonists
  • Platelet Function Tests
  • Platelet Aggregation Inhibitors
  • Pharmacogenetics
  • Humans
  • Genotype